e-learning
resources
Virtual 2021
05.09.2021
Biomarkers and e-health in idiopathic interstitial pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Blood Krebs von den Lungen-6 predicts mortality in patients with acute exacerbation of interstitial lung disease
M. Choi (Seoul, Republic of Korea), J. Yoon (Seoul, Republic of Korea), S. Choi (Seoul, Republic of Korea), J. Song (Seoul, Republic of Korea)
Source:
Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Session:
Biomarkers and e-health in idiopathic interstitial pneumonia
Session type:
E-poster
Number:
384
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Choi (Seoul, Republic of Korea), J. Yoon (Seoul, Republic of Korea), S. Choi (Seoul, Republic of Korea), J. Song (Seoul, Republic of Korea). Blood Krebs von den Lungen-6 predicts mortality in patients with acute exacerbation of interstitial lung disease. 384
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected non-small cell lung cancer
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
The prognostic factor in patients with myositis-associated interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Potential causes of acute deterioration in patients with interstitial lung disease
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – IPF and surroundings
Year: 2014
Physiological responses to functional exercise capacity in interstitial lung disease patients with acute exacerbations
Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions
Year: 2015
A proof of concept study by thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
Using the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Effects of pulmonary rehabilitation in patients with interstitial lung disease (ILD)
Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation
Year: 2009
Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease?
Source: International Congress 2014 – ILDs 5
Year: 2014
Does hypoxemia increases risks in hospitalized patients with diffuse interstitial lung disease?
Source: International Congress 2014 – ILDs 6
Year: 2014
Walking assessments as the predictor of acute respiratory failure in the interstitial lung disease patients.
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020
Acute exacerbations of interstitial lung disease
Source: Eur Respir Monogr 2016; 74: 117-131
Year: 2016
Nitrofurantoin-induced interstitial lung disease
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012
Investigation burden in patients with fibrotic interstitial lung disease in their terminal admission
Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Year: 2018
Circulating monocytes from interstitial lung disease patients show an activated phenotype
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Interstitial lung disease in elderly subjects
Source: Eur Respir Mon; 2009: 43: 150–162
Year: 2009
Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept